Skip to main content
Premium Trial:

Request an Annual Quote

Leonardo Receives Second Half of $2.5M Grant

Premium

Leonardo Biosystems said this week that it has received the second half of a $2.5 million grant from the Texas Emerging Technology Fund to help develop its multi-stage drug-delivery technology.

The first half of the grant was received in April 2010.

The drug-delivery technology involves a multi-stage system comprising mesoporous silicon particles containing neutral nanoliposomes carrying a drug payload.

Last year, Gene Silencing News reported that the company was aiming to use the grant funding to help ramp up its operations so that it could establish industry partnerships (GSN 10/27/2010).

The Scan

Steps for Quick Review

The US Food and Drug Administration is preparing for the quick review of drugs and vaccines for the Omicron variant, according to the Wall Street Journal.

Moving Away From Using Term 'Race'

A new analysis finds that geneticists are using the term "race" in their papers less than in years past, as Science reports.

Point of the Program

The Guardian writes that some scientists have called the design of a UK newborn sequencing program into question.

Science Papers Present Multi-Omic Analysis of Lung Cells, Regulation of Cardiomyocyte Proliferation

In Science this week: a multi-omic analysis of lung cells focuses on RIT1-regulated pathways, and more.